USX:BEAT - BioTelemetry Inc (USD 47.62) BioTelemetry, Inc
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
Add Alert 

Yahoo Finance

USD 47.62    +0.340 (+0.72%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

2 Jun 2020


2 Jun 2020

Day Change: 0.340 (0.72%)

52 Wk Range: 27.35 - 55.85

Day's Range: 46.62 - 48.28

Last Volume: 200,902

Current Yield: 0%

Projected Yield: 0%

Open: USD 47.35

2 Jun 2020

Metric BEAT S.Median
Beta 1.3 0.45
VaR 30.99 55.02
E.Shortfall 41.95 89.56
Liquidity 327.15K 2,718.04


2 Jun 2020

PE: 58.145

Market Cap: 1.7B

Price Over Book: 4.729

Price Over Sales: 3.95

Return On Assets: 4.4%

Return On Equity: 8.1%

Current Ratio: 3.019


CEO: Mr. Joseph H. Capper

IPO: 2008-03-18

Headquarters: US

Employees: 1,700

Sector: Health Technology

Industry: Medical Specialties

Useful Links


BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core lab services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in Healthcare, Research, and Corporate and Other segments. The Healthcare segment focuses on the remote cardiac monitoring to identify arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, and non-loop event monitors. It also provides Holter and extended-wear Holter monitors, and INR monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The Corporate and Other segment focuses on the manufacture, engineering, development, and sale of non-invasive cardiac monitors and other population health management devices for healthcare companies, as well as contract manufacturing services under the BioTel Care and BioTel Alliance names. The company was founded in 1994 and is headquartered in Malvern, Pennsylvania.